Results 241 to 250 of about 219,576 (296)

Beyond the conventional risk factors in the management of atherosclerosis in women: a call to action for careful consideration of obesity and inflammation. [PDF]

Eur Heart J Open
Alasnag M, Sambola A, Uchmanowicz I, Kaluzna M, Sabouret PF, Serrano L, Paradies V, Parapid B, Banerjee S, Bachelot A, Gilard M, Hawranek M, Kunadian V, Chieffo A, Mehran R, Silberman SM.   +15 more
europepmc   +1 more source

Pharmacological Management of Obesity in Pregnancy: A Review of Current and Emerging Therapies. [PDF]

Drugs
Fotheringham P, McGee RG, Chang R, Kennedy D, Simmons D.   +4 more
europepmc   +1 more source

GLP-1 guidelines amid an obesity epidemic: a poor fit for the Global South. [PDF]

Arch Public Health
Shrisunder R, Karmarkar V.
europepmc   +1 more source

Cardiovascular outcome trials (CVOTs) in cardiorenal metabolic medicine: a decade of transformative progress (2016-2026). [PDF]

Cardiovasc Diabetol
Wen S, Wang C, Xu Z, Chen L, He Y, Ren Y, Yuan Y, Li Y, Dong M, Gong M, Wang C, Li X, Xu D, Yuan X, Jin J, Li J, Zhou L.   +16 more
europepmc   +1 more source

Obesity, Low-Grade Chronic Inflammation, and Clinical Outcomes in Spondyloarthritis: A Translational Synthesis. [PDF]

Metabolites
Belančić A, Radić M, Rogoznica Pavlović M, Vučković M, Prižmić PŠ, Gkrinia EMM, Radić J, Fajkić A.   +7 more
europepmc   +1 more source

Potential health benefits of bromelain: a critical review of the current literature. [PDF]

Front Nutr
Sanlier N, Irmak E, Ankarali E.
europepmc   +1 more source

Semaglutide in obesity and type 2 diabetes: A review of clinical trial evidence from 1 to 5 semaglutide treatment effect in people with obesity program.

Indian J Pharmacol
Khanna A, Kumar V, Gola S.
europepmc   +1 more source